top of page

MedTech: What a Second Medical Molding Site Has to Prove

Writer: Evan Porter
Evan Porter
5 hours ago
3 min read

The date that matters in a medical mold transfer is the first day the receiving plant can release an approved production lot. If the original plant loses access to its only qualified mold when the tool ships, the buyer may be drawing down inventory while the new line is still running trials. Each extra trial eats into that buffer. Rosti Group’s acquisition of Alvi Group brings that problem into focus for medical-device manufacturers looking for a second source.


Rows of injection molding machines on a factory floor
Injection molding machines on a factory floor

Rosti closed the acquisition on November 2, adding five sites across Norway, Sweden, Poland and China. Those plants give medical-device buyers more places to look for capacity. How fast a plant can take over an existing part depends on what the buyer can carry over from the original production line and what its quality team needs to see from the new one. A delivery date for the mold accounts for only the first step of that process.


Karl Stillman, head of Rosti Medical Solutions
Karl Stillman, head of Rosti Medical Solutions. Photo supplied by Rosti Group.

What the New Plant Has to Prove


Karl Stillman, vice president of strategic business development and head of Rosti Medical Solutions, told The Supply Chainer that buyers can reuse approved drawings, material specifications, mold qualification records and historical validation data. That history gives the receiving team a starting point for its own trials. “Even when the same mold, materials, and process parameters are used, the OEM should verify that the new site can achieve equivalent quality, performance, and regulatory compliance before routine production begins,” Stillman said. He pointed to first-article inspection, checks on the measurement system and confirmation of traceability among the work still to be done at the receiving plant.


The Global Harmonization Task Force’s medical-device process validation guidance lists a transfer between facilities as a reason to consider revalidation. “The need for revalidation should be evaluated and documented,” the guidance states. It allows for a narrower scope when the circumstances do not warrant repeating the full original validation. For a buyer comparing two transfer bids, that makes the testing scope worth checking line by line. One quote may cover moving and installing the mold while another also budgets time for capability studies, trial runs and review of the results.


Build Stock to the Release Date


Stillman said the device maker and contract manufacturer should agree before the move on which tests to run, what counts as a pass, how many units to make in each run and when validation approval is expected. “These requirements should be established early so the original manufacturing site can build sufficient safety stock to support uninterrupted supply during the validation period,” he said. If a customer needs to approve the change, that review belongs on the same schedule. So does time for a repeat run if the first one misses the agreed criteria.


Where only one qualified mold is available, the old plant may be unable to replenish that stock once the tool leaves. A sourcing team can price that exposure by asking how much stock will be left if the first trial fails and the next available press slot is a week away. That calculation gives the buyer a basis for setting the final production run at the original site. It also gives procurement and quality a shared date to work toward, when the first lot from the receiving plant is cleared for use.

Join Our Newsletter

And get the latest news from The Supply Chainer directly to your email

Thanks for submitting!

The Supply Chainer's editorial team of experienced writers, editors and industry experts collaborates to produce high-quality content that tackles the dynamic challenges of the global supply chain landscape. We are dedicated to building a vibrant community of supply chain professionals while promoting knowledge sharing and industry innovation. ​ We don’t maintain social media accounts as a matter of principle. To find our editorials on social search: "The Supply Chainer"

Dark futuristic robot banner with CaPow logo.png

​

​​

The Supply Chainer© 2016 Watermark Publishers Group, Inc.  All Rights Reserved. 1209 Orange St. Wilmington, DE 19801, USA

​

bottom of page